Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Resonance Health Ltd

RHT.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Advanced Medical Equipment & Technology ·

Australia Micro Cap Analyst: N/A

Last Close

$0.04

▲ +0.00%

Market Cap $19.92M · Vol 534

Key Metrics

P/E Ratio

18.71

FWD: N/A

Market Cap

$19.92M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

58.62

Momentum

Beta

1.55

vs Market

52W High

$0.05

14.29% below

52W Low

$0.02

92.31% above

Volume

534

Avg 360.08K

P/B

1.89

Price-to-book

ROE

N/A

Return on equity

Free Float

59.36%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Resonance Health Ltd (RHT.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does RHT.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.75%

-3.33%

+45.00%

YTD

+18.37%

+65.71%

-0.75%

-49.57%

Financials & Valuation

TTM · Annual

Total Revenue	$10.91M
Net Income	$1.05M
Revenue Growth (YoY)	+32.11%
Gross Margin	100.00%
Operating Margin	9.82%
Net Profit Margin	9.60%
ROE	N/A
ROA · ROIC	6.00% · 14.08%

P/E Ratio	18.71
Forward P/E (FY1)	N/A
PEG Ratio	0.08
P/S	1.35
P/B	1.89
P/FCF	8.25
EPS Growth	N/A
Outstanding Shares	477.12M

Technical Indicators

50-Day SMA	$0.04
200-Day SMA	$0.03
RSI (14)	58.62
Beta	1.55
52-Week High	$0.05
52-Week Low	$0.02

Volume Today	534
Avg Daily Volume (30D)	360.08K
Relative Volume	0.00x
Volatility (10D)	83.31
Volatility (30D)	73.89
Free Float	59.36%

Analyst Consensus

N/A

Current Price $0.04

Mean Target N/A

52W Low$0.02 52W High$0.05

Current

Target

$0.02 $0.05

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001S8WN03

ISINAU000000RHT2

CountryAustralia

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -0.75% DHR Danaher Corp -1.60% ISRG Intuitive Surgical Inc -0.85% BSX Boston Scientific Corp +1.81% EW Edwards Lifesciences Corp +0.13%

Company Profile

Resonance Health Limited is an Australia-based healthcare technology and services company. The Company is engaged in the development and commercialization of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its segments include software-as-medical-device (SaMD), Corporate, Resonance Clinical, and TrialsWest. Its SaMD products incorporate such as Artificial Intelligence (AI) FerriScan, FerriSmart, HepaFatScan, HepaFatSmar, LiverSmart, and CardiacT2. FerriScan is a core-lab product that provides an accurate assessment of liver iron concentration (LIC) through non-invasive MRI-based technology, for use in the assessment of individuals with iron overload conditions. It operates as the Clinical Trial Research Organisation (CRO) and local sponsor for a major global pharma company's clinical trial in Australia of a new drug compound.